Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate Cancer [NA]

View source ↗

Summary

Clinical trial update for Alpha Tau Medical's DaRT alpha radiation emitter device in locally recurrent prostate cancer. The trial is currently not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DaRT (alpha radiation emitter device)

Snippet

Sponsor: Alpha Tau Medical LTD. | Conditions: Prostate Cancer, Recurrent Prostate Cancer | NA | Status: NOT_YET_RECRUITING